Information Support Using an Online Learning Platform for Malaysian Pediatric Leukemia and Lymphoma Parents
NCT05455268 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51
Last updated 2023-05-10
Summary
This is a study protocol to determine whether it is feasible to support parents of children with blood cancers by providing information over an online learning platform. This study will be conducted in Malaysia. An online learning platform will be used to provide information relevant to parents who care for children diagnosed with leukemia or lymphoma. The use of this platform will be compared with current usual care, where only verbal discussions and ad hoc caregiver training is provided to support these parents, based on the clinician's judgement. Participants knowledge and confidence level in caregiving as well as coping will be compared between the two groups. To determine the feasibility of this method of information support, the researchers will also obtain feedback from participants who used the online learning platform and determine whether there are many who drop out from using it. The findings will determine whether use of online learning platform is suitable to deliver information support for parents, in view of currently limited resources for supportive care in childhood cancer care in Malaysia.
Conditions
- Pediatric Acute Myeloid Leukemia
- Pediatric Acute Lymphoid Leukemia
- Pediatric Non-Hodgkin Lymphoma
- Pediatric Hodgkin Lymphoma
Interventions
- OTHER
-
eHOPE
e-Haematological Oncology Parents Education (eHOPE) consists of caregiving information for parents of children with leukaemia and lymphoma, presented in multimedia format through an online learning platform. The contents are developed in Malay language, encompassing basic information on disease and treatment, medical caregiving, emotional caregiving, appraising information, communication and self-care. Parents will be able to access multimedia information designed to support them in the care of their sick child. There are 4 self-paced activities in eHOPE with the following objectives: 1. Parents should be able to outline key tasks related to care for their child at home. 2. Parents should be able to outline strategies to initiate discussions with their child's healthcare providers. 3. Parents should be able to appraise reliability of information sources. 4. Parents should be able to identify coping strategies that they can use when faced with stressful situations.
- OTHER
-
Usual care
Face-to-face verbal discussions and caregiver training will be provided as deemed necessary by the clinicians.
Sponsors & Collaborators
-
Universiti Putra Malaysia
collaborator OTHER -
Ministry of Health, Malaysia
collaborator OTHER_GOV -
Universiti Kebangsaan Malaysia Medical Centre
lead OTHER
Principal Investigators
-
Chai Eng Tan · National University of Malaysia
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-07-15
- Primary Completion
- 2023-03-31
- Completion
- 2023-03-31
Countries
- Malaysia
Study Locations
More Related Trials
-
Targeted High Throughput Sequencing in the Diagnosis of Pediatric Acute Leukemia
NCT01991249 ·Status: COMPLETED ·Phase: NA
-
Culturally Adapted Parenting Intervention for Spanish-Speaking Parents in Improving Outcomes of Younger Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia Survivors at Risk for Late Neurocognitive Effects
NCT02559557 ·Status: COMPLETED ·Phase: NA
-
Hematotoxicity in Acute Lymphoblastic Leukemia Children in Maintenance Phase Therapy
NCT03279900 ·Status: COMPLETED
-
Malaysia-Singapore Acute Lymphoblastic Leukemia 2010 Study
NCT02894645 ·Status: UNKNOWN ·Phase: PHASE4
-
Optimizing 6-mercaptopurine Therapy in Pediatric Acute Lymphoblastic Leukemia by Using Allopurinol
NCT03022747 ·Status: UNKNOWN ·Phase: PHASE2
-
Donor-specific Allogeneic Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia (ALL)
NCT01037764 ·Status: TERMINATED ·Phase: PHASE2
-
Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL)
NCT00131053 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of the Intermediate Metabolism in Children With Acute Lymphoblastic Leukemia (ALL)
NCT03035344 ·Status: UNKNOWN
-
Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic Leukemia
NCT00022126 ·Status: COMPLETED ·Phase: PHASE2
-
Study of alloCART-19 Cell Therapy in Pediatric Patients With Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
NCT04173988 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Leukemia Adapted Protocol
NCT06928909 ·Status: RECRUITING
-
Bortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL)
NCT00440726 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of Treatment Efficacy According to Risk Group in Relapsed Childhood Acute Lymphoblastic Leukemia
NCT05827549 ·Status: RECRUITING ·Phase: PHASE2
-
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
NCT01861002 ·Status: COMPLETED ·Phase: PHASE1
-
Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia
NCT00343369 ·Status: UNKNOWN ·Phase: NA
-
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia
NCT00005596 ·Status: COMPLETED ·Phase: PHASE3
-
Multicenter Study of Combined Chemotherapy and Transplantation for Adult ALL
NCT07059156 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2008
NCT01953770 ·Status: UNKNOWN ·Phase: NA
-
Haplo-identical HSCT Versus Chemotherapy for Adult Acute Lymphoblastic Leukemia Patients
NCT02042690 ·Status: COMPLETED ·Phase: PHASE3
-
ETOILE : A Feasibility Study in Pediatric Patient Education
NCT04399863 ·Status: COMPLETED ·Phase: NA
-
A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
NCT04307576 ·Status: RECRUITING ·Phase: PHASE3
-
Alemtuzumab and Pentostatin In T-cell Neoplasms
NCT00453193 ·Status: TERMINATED ·Phase: PHASE2
-
FoxO3a and PU.1 in Acute Lymphoblastic Leukemia
NCT04092348 ·Status: UNKNOWN
-
Azacitidine and Homoharringtonine in JMML
NCT04505995 ·Status: UNKNOWN ·Phase: NA
-
Trial to Assess the Efficacy of a TCR Alfa Beta Depleted Graft in Pediatric Affected by ALL or AML and Receiving an HSCT
NCT01810120 ·Status: COMPLETED ·Phase: PHASE1/PHASE2